Literature DB >> 9767400

The cytokine network of wallerian degeneration: IL-10 and GM-CSF.

H Be'eri1, F Reichert, A Saada, S Rotshenker.   

Abstract

Wallerian degeneration (WD) is the inflammatory response of peripheral nerves to injury. Evidence is provided that granulocyte macrophage colony stimulating factor (GM-CSF) contributes to the initiation and progression of WD by activating macrophages and Schwann, whereas IL-10 down-regulates WD by inhibiting GM-CSF production. A significant role of activated macrophages and Schwann for future regeneration is myelin removal by phagocytosis and degradation. We studied the timing and magnitude of GM-CSF and IL-10 production, macrophage and Schwann activation, and myelin degradation in C57BL/6NHSD and C57BL/6-WLD/OLA/NHSD mice that display normal rapid-WD and abnormal slow-WD, respectively. We observed the following events in rapid-WD. The onset of GM-CSF production is within 5 h after injury. Production is steadily augmented during the first 3 days, but is attenuated thereafter. The onset of production of the macrophage and Schwann activation marker Galectin-3/MAC-2 succeeds that of GM-CSF. Galectin-3/MAC-2 production is up-regulated during the first 6 days, but is down-regulated thereafter. The onset of myelin degradation succeeds that of Galectin-3/MAC-2, and is almost complete within 1 week. IL-10 production displays two phases. An immediate low followed by a high that begins on the fourth day, reaching highest levels on the seventh. The timing and magnitude of GM-CSF production thus enable the rapid activation of macrophages and Schwann that consequently phagocytose and degrade myelin. The timing and magnitude of IL-10 production suggest a role in down-regulating WD after myelin is removed. In contrast, slow-WD nerves produce low inefficient levels of GM-CSF and IL-10 throughout. Therefore, deficient IL-10 levels cannot account for inefficient GM-CSF production, whereas deficient GM-CSF levels may account, in part, for slow-WD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767400

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  23 in total

1.  Analysis of the immune response to sciatic nerve injury identifies efferocytosis as a key mechanism of nerve debridement.

Authors:  Ashley L Kalinski; Choya Yoon; Lucas D Huffman; Patrick C Duncker; Rafi Kohen; Ryan Passino; Hannah Hafner; Craig Johnson; Riki Kawaguchi; Kevin S Carbajal; Juan Sebastian Jara; Edmund Hollis; Daniel H Geschwind; Benjamin M Segal; Roman J Giger
Journal:  Elife       Date:  2020-12-02       Impact factor: 8.140

2.  A Role for Inflammation in Chronic Pain.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 3.  The neuroprotective role of inflammation in nervous system injuries.

Authors:  Jorge Correale; Andrés Villa
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 4.  The neuroimmunology of degeneration and regeneration in the peripheral nervous system.

Authors:  A DeFrancesco-Lisowitz; J A Lindborg; J P Niemi; R E Zigmond
Journal:  Neuroscience       Date:  2014-09-19       Impact factor: 3.590

Review 5.  Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells.

Authors:  Nevena Tzekova; André Heinen; Patrick Küry
Journal:  J Clin Immunol       Date:  2014-04-17       Impact factor: 8.317

6.  Characterization of Endoneurial Fibroblast-like Cells from Human and Rat Peripheral Nerves.

Authors:  Laurence Richard; Nicolas Védrenne; Jean-Michel Vallat; Benoît Funalot
Journal:  J Histochem Cytochem       Date:  2014-03-26       Impact factor: 2.479

7.  The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta.

Authors:  Shlomit Shamash; Fanny Reichert; Shlomo Rotshenker
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

8.  Clonidine reduces hypersensitivity and alters the balance of pro- and anti-inflammatory leukocytes after local injection at the site of inflammatory neuritis.

Authors:  Alfonso Romero-Sandoval; James C Eisenach
Journal:  Brain Behav Immun       Date:  2006-10-31       Impact factor: 7.217

Review 9.  Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease.

Authors:  Shlomo Rotshenker
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

10.  Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve.

Authors:  Elizabeth I Girolami; Delphine Bouhy; Michael Haber; Howard Johnson; Samuel David
Journal:  Exp Neurol       Date:  2009-07-02       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.